Sirnaomics-B (02257) Issues 2.50 Million New Shares at HK$12, Enlarging Share Capital by 2.33%

Bulletin Express03-09

Sirnaomics Ltd. (stock code: 02257) has disclosed a change in its share capital following the completion of a share subscription conducted under the company’s general mandate.

On 9 March 2026, the RNA therapeutics developer allotted 2.50 million new ordinary shares at an issue price of HK$12.00 per share, pursuant to a subscription agreement signed on 7 September 2025. The transaction expands Sirnaomics’ issued share capital by 2.33%, lifting the total number of issued shares (excluding treasury shares) from 107.22 million to 109.72 million.

The company confirmed it held no treasury shares before or after the transaction, and no shares were repurchased, redeemed, or sold from treasury during the period covered. The board affirmed that all proceeds have been duly received, and the issuance complied with Hong Kong Stock Exchange listing rules and other regulatory requirements.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1153769661?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-09 17:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1153769661","market":"hk","top_or_hot":-1,"title":"Sirnaomics-B (02257) Issues 2.50 Million New Shares at HK$12, Enlarging Share Capital by 2.33%","media":"Bulletin Express","content":"<p>Sirnaomics Ltd. (stock code: 02257) has disclosed a change in its share capital following the completion of a share subscription conducted under the company’s general mandate.</p>\n<p>On 9 March 2026, the RNA therapeutics developer allotted 2.50 million new ordinary shares at an issue price of HK$12.00 per share, pursuant to a subscription agreement signed on 7 September 2025. The transaction expands Sirnaomics’ issued share capital by 2.33%, lifting the total number of issued shares (excluding treasury shares) from 107.22 million to 109.72 million.</p>\n<p>The company confirmed it held no treasury shares before or after the transaction, and no shares were repurchased, redeemed, or sold from treasury during the period covered. The board affirmed that all proceeds have been duly received, and the issuance complied with Hong Kong Stock Exchange listing rules and other regulatory requirements.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sirnaomics-B (02257) Issues 2.50 Million New Shares at HK$12, Enlarging Share Capital by 2.33%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSirnaomics-B (02257) Issues 2.50 Million New Shares at HK$12, Enlarging Share Capital by 2.33%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-09 17:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Sirnaomics Ltd. (stock code: 02257) has disclosed a change in its share capital following the completion of a share subscription conducted under the company’s general mandate.</p>\n<p>On 9 March 2026, the RNA therapeutics developer allotted 2.50 million new ordinary shares at an issue price of HK$12.00 per share, pursuant to a subscription agreement signed on 7 September 2025. The transaction expands Sirnaomics’ issued share capital by 2.33%, lifting the total number of issued shares (excluding treasury shares) from 107.22 million to 109.72 million.</p>\n<p>The company confirmed it held no treasury shares before or after the transaction, and no shares were repurchased, redeemed, or sold from treasury during the period covered. The board affirmed that all proceeds have been duly received, and the issuance complied with Hong Kong Stock Exchange listing rules and other regulatory requirements.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02257","symbol_name":"圣诺医药-B","start_time":0,"source_url":"","article_id":"1153769661","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1153769661","pubTimestamp":1773049382,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Sirnaomics Ltd. (stock code: 02257) has disclosed a change in its share capital following the completion of a share subscription conducted under the company’s general mandate. On 9 March 2026, the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02257":"圣诺医药-B"},"translate_title":"圣诺-B(02257)12港元发行250万股新股扩大股本2.33%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02257":1},"content_text":"Sirnaomics Ltd. (stock code: 02257) has disclosed a change in its share capital following the completion of a share subscription conducted under the company’s general mandate.\nOn 9 March 2026, the RNA therapeutics developer allotted 2.50 million new ordinary shares at an issue price of HK$12.00 per share, pursuant to a subscription agreement signed on 7 September 2025. The transaction expands Sirnaomics’ issued share capital by 2.33%, lifting the total number of issued shares (excluding treasury shares) from 107.22 million to 109.72 million.\nThe company confirmed it held no treasury shares before or after the transaction, and no shares were repurchased, redeemed, or sold from treasury during the period covered. The board affirmed that all proceeds have been duly received, and the issuance complied with Hong Kong Stock Exchange listing rules and other regulatory requirements.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1153769661","isCrawlerRequest":true}